Of the 20 patients who were tested containing HNF1β, WT-1, ER, and PR, 11 (55%) had the combination of positive HNF1β, and negative WT-1, ER, and PR characteristics for the diagnosis of clear cell carcinoma. The gene discussed is ESR1; the disease is clear cell adenocarcinoma.